Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ARCA BIOPHARMA, INC.

(ABIO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

ARCA biopharma : Enrolls First International Patient in Phase 2b Trial of rNAPc2 to Treat COVID-19

09/16/2021 | 09:15am EDT


ę MT Newswires 2021
All news about ARCA BIOPHARMA, INC.
09/16ARCA BIOPHARMA : Announces Enrollment of First International Patient in Phase 2b Clinical ..
PU
09/16ARCA BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
09/16ARCA BIOPHARMA : Enrolls First International Patient in Phase 2b Trial of rNAPc2 to Treat ..
MT
09/16ARCA BIOPHARMA : Announces Enrollment of First International Patient in Phase 2b Clinical ..
AQ
09/16ARCA Biopharma, Inc. Announces Enrollment of First International Patient in Phase 2B Cl..
CI
08/16ARCA BIOPHARMA : to Present at the Q3 Virtual Investor Summit on August 18th
AQ
08/09ARCA BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
08/09ARCA biopharma Announces Submission of PCT Patent Application for the Treatment of Coro..
CI
08/09ARCA biopharma Announces Submission of PCT Patent Application for the Treatment of Coro..
GL
08/04ARCA BIOPHARMA : Announces Second Quarter 2021 Financial Results and Provides Corporate Up..
PU
More news
Financials (USD)
Sales 2020 - - -
Net income 2020 -9,74 M - -
Net cash 2020 48,6 M - -
P/E ratio 2020 -1,94x
Yield 2020 -
Capitalization 40,2 M 40,2 M -
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees 13
Free-Float 99,6%
Chart ARCA BIOPHARMA, INC.
Duration : Period :
ARCA biopharma, Inc. Technical Analysis Chart | ABIO | US00211Y5069 | MarketScreener
Technical analysis trends ARCA BIOPHARMA, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
Michael R. Bristow President, Chief Executive Officer & Director
C. Jeffrey Dekker Chief Financial Officer
Robert E. Conway Chairman
Debra Marshall Chief Medical Officer
Thomas A. Keuer Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
ARCA BIOPHARMA, INC.-30.42%40
CSL LIMITED5.08%100 638
WUXI BIOLOGICS (CAYMAN) INC.6.42%59 673
SAMSUNG BIOLOGICS CO.,LTD.5.21%48 619
BIOGEN INC.16.50%41 907
ALEXION PHARMACEUTICALS, INC.0.00%40 336